Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02406573 · ClinicalTrials.gov registry record · NA
A Pilot Study to Assess Nominal Versus Controlled Stimuli on Dentinal Hypersensitivity
A NA study of Dentin Sensitivity, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT02406573: Completed NA study of Dentin Sensitivity, sponsored by Procter and Gamble.
NCT02406573 is a NA study of Dentin Sensitivity that has completed, run by Procter and Gamble. The registered enrollment target is 30 participants, below the 267-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02406573, a NA study of Dentin Sensitivity, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study will evaluate the use of nominal stimuli to assess dentinal hypersensitivity response relative to a clinically-controlled stimulus.
Primary Outcome
Visual Analog Scale (VAS) - subjects are asked to look at a VAS and designate the level of hypersensitivity they experienced as a result of the thermal and water challenges using a continuum scale of 0 = No tooth pain up to 100 = Worst tooth pain ever experienced.
Conditions Studied
Interventions
- DEVICE Crest® Sensi-Stop™ Strips
Study Locations (1)
Ohio
- Oral Health Science Center - Mason
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT02406573 record still lists
NCT02406573 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 267-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Dentin Sensitivity appearing as the primary indexed condition, and to 1 intervention - of which Crest® Sensi-Stop™ Strips is the first listed.
NCT02406573 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02406573 about?
NCT02406573 is a clinical study titled "A Pilot Study to Assess Nominal Versus Controlled Stimuli on Dentinal Hypersensitivity". This pilot study will evaluate the use of nominal stimuli to assess dentinal hypersensitivity response relative to a clinically-controlled stimulus.
What is the current status of trial NCT02406573?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-03. Estimated completion is 2015-04.
What conditions does trial NCT02406573 study?
This clinical trial studies the following conditions: Dentin Sensitivity.
What interventions are being tested in trial NCT02406573?
The interventions under investigation include: Crest® Sensi-Stop™ Strips (DEVICE).
Who is sponsoring clinical trial NCT02406573?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02406573 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dentin Sensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real-World Study of a Calcium Sodium Phosphosilicate Anti-Sensitivity Toothpaste for Dentin Hypersensitivity Relief
RECRUITING · NA
-
Effectiveness of Two Water-Based Potassium Oxalate Desensitizers
COMPLETED · NA
-
A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia